REMOXIPRIDE
| SMILES | CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC |
| InChIKey | GUJRSXAPGDDABA-NSHDSACASA-N |
Chemical properties
| Hydrogen bond acceptors | 4 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 6 |
| Molecular weight (Da) | 370.1 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| D3 | DRD3 | Green monkey | Dopamine | A | pKi | 5.34 | 5.34 | 5.34 | ChEMBL |
| D2 | DRD2 | Green monkey | Dopamine | A | pKi | 6.06 | 6.06 | 6.06 | ChEMBL |
| D4 | DRD4 | Human | Dopamine | A | pKi | 5.41 | 5.41 | 5.41 | ChEMBL |
| 5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKd | 5.4 | 5.4 | 5.4 | ChEMBL |
| 5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKd | 8.27 | 8.27 | 8.27 | Drug Central |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.26 | 8.26 | 8.26 | Drug Central |
| D3 | DRD3 | Human | Dopamine | A | pKi | 8.15 | 8.15 | 8.15 | Drug Central |
| D4 | DRD4 | Human | Dopamine | A | pKi | 8.27 | 8.27 | 8.27 | Drug Central |
| D2 | DRD2 | Green monkey | Dopamine | A | pKi | 8.22 | 8.22 | 8.22 | Drug Central |
| D3 | DRD3 | Green monkey | Dopamine | A | pKi | 8.27 | 8.27 | 8.27 | Drug Central |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| D2 | DRD2 | Rat | Dopamine | A | pIC50 | 5.8 | 5.82 | 5.85 | ChEMBL |
| D4 | DRD4 | Human | Dopamine | A | pIC50 | 5.41 | 5.41 | 5.41 | ChEMBL |
| D2 | DRD2 | Human | Dopamine | A | pIC50 | 6.06 | 7.49 | 8.92 | ChEMBL |
| D2 | DRD2 | Human | Dopamine | A | pIC50 | 8.22 | 8.22 | 8.22 | Drug Central |
| D2 | DRD2 | Rat | Dopamine | A | pIC50 | 8.23 | 8.23 | 8.23 | Drug Central |